The day's most important news and information. A Fourth Estate® Service

Monday, June 21, 2021
Moderna announced on Monday morning that its experimental vaccine was 94.5 percent effective in preventing COVID-19 based on interim data from a late-stage trial, becoming the second drugmaker in the United States to report results that exceed expectations.

This article is archived.

Subscribe or log in to the Daily Newsbrief and gain access.

 

Premium Access

Unlimited access is just $1 /week
You can cancel anytime.
  • Unlimited articles with no ads
  • Access with any of your devices
  • Access to archived articles
  • The Daily News Brief newsletter
  • Special offers
  • Early access to new features

 
 

Not ready for a subscription? Simply sign up here
(no credit card required) to get 5 free articles each month.